ArticleJournal of Cancer2020

Use of eribulin as an earlier-line chemotherapy for patients with HER2-negative metastatic breast cancer.

Sumito Shingaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.